Adjuvant Subcutaneous Interleukin-2 in Patients with Resected Renal Cell Carcinoma: A Pilot Study
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference39 articles.
1. Current staging of renal cell carcinoma;Leibovich;Urol Clin North Am,2003
2. Prognostic factors in renal carcinoma;Rini;Semin Oncol,2000
3. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system;Gettman;Cancer,2001
4. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria;Tsui;J Urol,2000
5. Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases;Ficarra;Eur Urol,2002
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Emerging Strategies in Adjuvant Immunotherapy: A Comparative Review of Bladder Cancer and Renal Cell Carcinoma Treatments;Clinical Medicine Insights: Oncology;2024-01
2. Adjuvant therapy for renal cell carcinoma: A systematic review of current landscape and future directions;Critical Reviews in Oncology/Hematology;2023-12
3. State of the Art: Multidisciplinary Management of Oligometastatic Renal Cell Carcinoma;American Society of Clinical Oncology Educational Book;2023-06
4. The Continuing Question of Adjuvant Therapy in Clear Cell Renal Cell Carcinoma;Cancers;2022-12-07
5. Immunotherapy for metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2017-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3